Xencor, Inc Pre-Tax Income
Xencor, Inc (XNCR) reported Pre-Tax Income of -$21.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-05
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$21.92M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$128.64M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$4.27M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$6.03M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$89.63M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$234.92M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$119.63M.
- Xencor, Inc income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$54.51M, a 165.97% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.92M 10-Q · filed 2026-08-05 | -$150.56M 10-Q · filed 2026-08-05 | -$154.82M derived: sum of 3 quarters · filed 2026-08-05 | -$160.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$128.64M 10-Q · filed 2026-05-06 | -$132.90M derived: sum of 2 quarters · filed 2026-05-06 | -$138.93M derived: sum of 3 quarters · filed 2026-05-06 | -$170.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$10.29M derived: sum of 2 quarters · filed 2026-02-25 | -$41.37M derived: sum of 3 quarters · filed 2026-08-05 | -$89.63M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$6.03M 10-Q · filed 2025-11-05 | -$37.10M derived: sum of 2 quarters · filed 2026-08-05 | -$85.37M 10-Q · filed 2025-11-05 | -$129.95M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$31.07M 10-Q · filed 2026-08-05 | -$79.34M 10-Q · filed 2026-08-05 | -$123.92M derived: sum of 3 quarters · filed 2026-08-05 | -$171.37M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$48.27M 10-Q · filed 2026-05-06 | -$92.85M derived: sum of 2 quarters · filed 2026-05-06 | -$140.29M derived: sum of 3 quarters · filed 2026-05-06 | -$209.07M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$44.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$92.03M derived: sum of 2 quarters · filed 2026-02-25 | -$160.81M derived: sum of 3 quarters · filed 2026-02-25 | -$234.92M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$47.44M 10-Q · filed 2025-11-05 | -$46.30M 10-Q · filed 2024-11-06 | -$116.22M derived: sum of 2 quarters · filed 2025-11-05 | -$190.34M 10-Q · filed 2025-11-05 | -$182.30M 10-Q · filed 2024-11-06 | -$202.99M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$68.78M 10-Q · filed 2025-08-06 | -$67.29M 10-Q · filed 2024-08-05 | -$142.90M 10-Q · filed 2025-08-06 | -$136.00M 10-Q · filed 2024-08-05 | -$155.55M derived: sum of 3 quarters · filed 2026-02-25 | -$179.81M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$74.12M 10-Q · filed 2025-05-07 | -$86.76M derived: sum of 2 quarters · filed 2026-02-25 | -$111.03M derived: sum of 3 quarters · filed 2026-02-25 | -$132.99M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$36.92M derived: sum of 2 quarters · filed 2026-02-25 | -$58.87M derived: sum of 3 quarters · filed 2026-02-25 | -$119.63M 10-K · filed 2026-02-25 | -$120.44M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$24.27M 10-Q · filed 2024-11-06 | -$46.22M derived: sum of 2 quarters · filed 2024-11-06 | -$106.99M 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | -$21.95M 10-Q · filed 2024-08-05 | -$82.72M 10-Q · filed 2024-08-05 | ||||||
| 2022-12-31 | -$12.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$44.13M derived: sum of 2 quarters · filed 2025-02-27 | -$54.51M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | -$31.67M 10-Q · filed 2023-11-08 | -$42.05M 10-Q · filed 2023-11-08 | ||||||
| 2021-12-31 | $73.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $32.87M derived: sum of 2 quarters · filed 2025-02-24 | $82.63M 10-K/A · filed 2025-02-24 | |||||
| 2021-09-30 | -$40.19M 10-Q · filed 2022-11-07 | $9.57M 10-Q · filed 2022-11-07 | ||||||
| 2020-12-31 | -$13.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$26.24M derived: sum of 2 quarters · filed 2023-02-27 | -$61.26M derived: sum of 3 quarters · filed 2023-02-27 | -$69.33M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | -$12.55M 10-Q · filed 2020-11-06 | -$47.57M derived: sum of 2 quarters · filed 2020-11-06 | -$55.64M 10-Q · filed 2020-11-06 | -$82.84M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$35.02M 10-Q · filed 2020-08-05 | -$43.09M 10-Q · filed 2020-08-05 | -$70.29M derived: sum of 3 quarters · filed 2022-02-24 | -$80.87M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$8.07M 10-Q · filed 2020-05-08 | -$35.27M derived: sum of 2 quarters · filed 2022-02-24 | -$45.85M derived: sum of 3 quarters · filed 2022-02-24 | -$61.83M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$27.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$37.77M derived: sum of 2 quarters · filed 2022-02-24 | -$53.76M derived: sum of 3 quarters · filed 2022-02-24 | $27.19M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$10.57M 10-Q · filed 2020-11-06 | -$26.56M derived: sum of 2 quarters · filed 2020-11-06 | $54.39M 10-Q · filed 2020-11-06 | $36.19M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$15.98M 10-Q · filed 2020-08-05 | $64.96M 10-Q · filed 2020-08-05 | $46.76M derived: sum of 3 quarters · filed 2021-02-24 | $49.91M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $80.94M 10-Q · filed 2020-05-08 | $62.75M derived: sum of 2 quarters · filed 2021-02-24 | $65.90M derived: sum of 3 quarters · filed 2021-02-24 | $40.03M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$15.05M derived: sum of 2 quarters · filed 2021-02-24 | -$40.92M derived: sum of 3 quarters · filed 2021-02-24 | -$70.41M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $3.15M 10-Q · filed 2019-11-05 | -$22.72M derived: sum of 2 quarters · filed 2019-11-05 | -$52.21M 10-Q · filed 2019-11-05 | -$45.93M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$25.87M 10-Q · filed 2019-08-07 | -$55.36M 10-Q · filed 2019-08-07 | -$49.08M derived: sum of 3 quarters · filed 2020-02-25 | -$71.56M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$29.49M 10-Q · filed 2019-05-09 | -$23.21M derived: sum of 2 quarters · filed 2020-02-25 | -$45.69M derived: sum of 3 quarters · filed 2020-02-25 | -$53.14M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$16.20M derived: sum of 2 quarters · filed 2020-02-25 | -$23.64M derived: sum of 3 quarters · filed 2020-02-25 | -$38.95M 10-K · filed 2020-02-25 | -$49.39M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | -$22.48M 10-Q · filed 2018-11-05 | -$15.39M 10-Q · filed 2017-11-08 | -$29.92M derived: sum of 2 quarters · filed 2018-11-05 | -$45.23M 10-Q · filed 2018-11-05 | -$36.46M 10-Q · filed 2017-11-08 | -$32.95M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$7.45M 10-Q · filed 2018-08-07 | -$6.61M 10-Q · filed 2017-08-07 | -$22.75M 10-Q · filed 2018-08-07 | -$21.07M 10-Q · filed 2017-08-07 | -$10.47M derived: sum of 3 quarters · filed 2019-02-26 | -$19.15M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | -$15.30M 10-Q · filed 2018-05-07 | -$14.46M 10-Q · filed 2017-05-10 | -$3.03M derived: sum of 2 quarters · filed 2019-02-26 | -$11.70M derived: sum of 3 quarters · filed 2019-02-26 | $37.21M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.60M derived: sum of 2 quarters · filed 2019-02-26 | $52.52M derived: sum of 3 quarters · filed 2019-02-26 | $46.12M 10-K · filed 2019-02-26 | $24.62M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$8.68M 10-Q · filed 2017-11-08 | $40.24M derived: sum of 2 quarters · filed 2017-11-08 | $33.84M 10-Q · filed 2017-11-08 | $41.60M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $48.91M 10-Q · filed 2017-08-07 | $42.52M 10-Q · filed 2017-08-07 | $50.27M derived: sum of 3 quarters · filed 2018-02-28 | $40.24M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | -$6.40M 10-Q · filed 2017-05-10 | $1.36M derived: sum of 2 quarters · filed 2018-02-28 | -$8.68M derived: sum of 3 quarters · filed 2018-02-28 | -$17.55M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$2.28M derived: sum of 2 quarters · filed 2018-02-28 | -$11.15M derived: sum of 3 quarters · filed 2018-02-28 | -$17.59M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | -$10.04M 10-Q · filed 2016-11-02 | -$18.91M derived: sum of 2 quarters · filed 2016-11-02 | -$25.35M 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | -$8.87M 10-Q · filed 2016-08-03 | -$15.31M 10-Q · filed 2016-08-03 | ||||||
| 2014-12-31 | -$16.42M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |